Thrombotic disease has been listed as the third most fatal vascular disease in the world.
After decades of development, clinical thrombolytic drugs still cannot avoid the occurrence of …

The diseases caused by two pathological processes, thrombosis, and thromboembolism,
are clinically known as thrombotic diseases, which seriously threaten human life and health …

A thrombus is a blood clot that forms in the lumen of an artery or vein, restricting blood flow
and causing clinical symptoms. Thrombosis is associated with many life‐threatening …

Thrombus has long been the major contributor of death and disability because it can cause
adverse effects to varying degrees on the body, resulting in vascular blockage, embolism …

Due to the high morbidity and mortality of cardiovascular diseases, there is an urgent need
for research on antithrombotic strategies. In view of the short half-life, insufficient drug …

Thrombotic occlusions of blood vessels are responsible for life-threatening cardiovascular
disorders such as myocardial infarction, ischemic stroke, and venous thromboembolism …

Thrombus formed in blood vessel is a progressive process, which would lead to life-
threatening thrombotic diseases such as ischemic stroke. Unlike other diseases, the …

This review highlights the preclinical and clinical research based on the use of nano-and
micro-carriers in thrombolytic drug delivery. Ischemic heart and stroke caused by thrombosis …

Objective: The objective of this work is to design and fabricate a novel multifunctional
nanocarrier combining thrombus-targeted imaging and ultrasound-mediated drug delivery …

Thrombosis is the major cause of cardiovascular diseases. Only a small subset of patients
could benefit from thrombolytic therapy due to the high bleeding risk brought about by the …